Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067/ADAPT Study

ABSTRACT The HPTN 067/ADAPT Study evaluated the feasibility, acceptability, patterns of adherence and coverage for three randomly assigned oral FTC/TDF pre-exposure prophylaxis (PrEP) dosing regimens to prevent HIV infection. Using qualitative methods, we explored facilitators and barriers among a subset of men who have sex with men (MSM) participants in Bangkok, Thailand. Between August 2013 and March 2014, 32 HPTN 067/ADAPT participants joined in 6 focus group discussions, and 6 attended key informant interviews. Facilitators of PrEP adherence included use of strategies to have PrEP available when needed, simplicity in regimen requirements with recognition that more complex regimens may take some time to master, ability to plan for sex, receipt of social and technology support, ability to use a PrEP regimen that best matches to one’s own patterns of sex, and experiences with PrEP as a part of health and well-being. Challenges to PrEP adherence included perceptions of no or low HIV risk, difficulties following regimens when intoxicated, concerns about side effects, experience of HIV stigma, and affordability of PrEP outside of study context influencing uptake and use in the community. Preferences for regimens varied, suggesting that multiple PrEP effective regimen options should be available to fit those with different needs.

[1]  T. Holtz,et al.  Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  R. Grant,et al.  Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. , 2017, The lancet. HIV.

[3]  T. Holtz,et al.  Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006-13: an observational study. , 2015, The lancet. HIV.

[4]  Moffat Joel Matyanga Celia Pre-exposure Prophylaxis for HIV Prevention , 2014 .

[5]  Megha L Mehrotra,et al.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. , 2014, The Lancet. Infectious diseases.

[6]  K. Amico,et al.  Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  S. Karim,et al.  Topical Microbicides—What's New? , 2013, Journal of acquired immune deficiency syndromes.

[8]  T. Holtz,et al.  HIV and Syphilis Infection Among Men Who Have Sex with Men — Bangkok, Thailand, 2005–2011 , 2013, MMWR. Morbidity and mortality weekly report.

[9]  B. Gazzard,et al.  Controlling the HIV Epidemic with Antiretrovirals , 2013, Journal of the International Association of Providers of AIDS Care.

[10]  J. Baeten,et al.  Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don’t We Know? , 2013, Current HIV/AIDS Reports.

[11]  B. Friedland,et al.  Microbicide clinical trial adherence: insights for introduction , 2013, Journal of the International AIDS Society.

[12]  J. Baeten,et al.  Oral antiretroviral chemoprophylaxis: current status , 2012, Current opinion in HIV and AIDS.

[13]  K. Amico,et al.  Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness , 2012, Current opinion in HIV and AIDS.

[14]  Peter L. Anderson,et al.  Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men , 2012, Science Translational Medicine.

[15]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[16]  Stefan D Baral,et al.  Global epidemiology of HIV infection in men who have sex with men , 2012, The Lancet.

[17]  H. Xi-ping,et al.  HIV and syphilis infections among men who have sex with men , 2012 .

[18]  C. Celum HIV Preexposure Prophylaxis : New Data and Potential Use therapy , 2012 .

[19]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[20]  Pai-Lien Chen,et al.  Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial , 2008, Sexually transmitted diseases.

[21]  K. Squires,et al.  Once-daily antiretroviral therapies for HIV infection: Consensus statement of an Advisory Committee of the International Association of Physicians in AIDS Care , 2002, Journal of the International Association of Physicians in AIDS Care.